| The first efforts
of the
Department of Neuroaugmentive Surgery
(NAS) at Sister Kenny Institute were
directed to avoiding unnecessary complications and
to improve reliability by decreasing component
failure through better materials and designs. The
single most important initial contribution at that
time was was the
development of the intradural stimulating electrode.
The physicians of NAS were instrumental in setting up the
neurosurgical criteria for patient screening as well as the
establishment of the CPT coding for implanted electronic
devices. At this point in time one of the greatest
failings in regard to the use of neurostimulating devices is
poor patient selection. This is particularly true when
patients are on significant amounts of opioid narcotics and, for
this reason, are not producing endogenous opioids (endorphins).
With appropriate patient selection and screening and
implantation being performed by well trained and experienced
surgeons complications are few and when they occur are only an
inconvenience rather than a disaster for the patient.
|